Overview
Lobbying Costs
280,000€
Financial year: Apr 2020 - Mar 2021
Lobbyists (Full time equivalent)
1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Kirkland Consulting
EU Transparency Register
371804028416-30 First registered on 21 Sep 2017
Goals / Remit
To provide scientific advice to companies, organisations and regulatory agencies on issues related to genotoxicity testing of chemical substances and interpretation of results.
Main EU files targeted
Clinical trial applications for pharmaceuticals, marketing applications for pharmaceuticals, REACH regulation for chemicals, EFSA assessment of food flavours and ingredients, cosmetics regulation, pesticides regulation, assessment of the safety of natural products (e.g. herbal remedies).
Website
-
People
Total lobbyists declared
1
Employment time Lobbyists 100% 1 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Self-employed individuals
-
Networking
Affiliation
Trustee of the European Environmental Mutagenesis and Genomics Society.
Emeritus Member of the US Environmental Mutagenesis and Genomics Society.
Health and Environmental Sciences Institute (HESI)Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Apr 2020 - Mar 2021
Lobbying costs for closed financial year
280,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount Novartis Pharma AG Pharmaceutical clinical trial application 0€ - 10,000€ NXTLEVVEL Biochem BV REACH registration 0€ - 10,000€ Consumer Healthcare Products Association Safety of acetaminophen 0€ - 10,000€ Bayer Animal Health Veterinary medicine 0€ - 10,000€ Boehringer Ingelheim Pharmaceutical pre-clinical safety 0€ - 10,000€ galapagos pharma Pharmaceutical pre-clinical safety 0€ - 10,000€ Endura Safety of biocides 0€ - 10,000€ medical ethics Veterinary medicine 0€ - 10,000€ EPPA SA Cosmetics safety 0€ - 10,000€ Toxicology Regulatory Services Safety of food ingredient 0€ - 10,000€ Albaugh Europe Sarl Pesticide safety 0€ - 10,000€ European Precious Metals Federation REACH registration 0€ - 10,000€ DSM NUTRITIONAL PRODUCTS Safety of food ingredients 0€ - 10,000€ MerLion Pharmaceuticals GmbH Pharmaceutical pre-clinical safety 0€ - 10,000€ Abliva AB Pharmaceutical pre-clinical safety 0€ - 10,000€ saqual GmbH REACH registration 0€ - 10,000€ Neurocycle Therapeutics Pharmaceutical pre-clinical safety 0€ - 10,000€ Benevolent AI Pharmaceutical pre-clinical safety 0€ - 10,000€ Titanium Dioxide Manufacturers Association REACH registration 0€ - 10,000€ European Aluminium Association REACH registration 0€ - 10,000€ Destiny Pharma Pharmaceutical pre-clinical safety 0€ - 10,000€ Genentech Pharmaceutical pre-clinical safety 0€ - 10,000€ Leveret GmbH Safety of food flavourings 0€ - 10,000€ Summit Pharmaceuticals Pharmaceutical pre-clinical safety 0€ - 10,000€ Medherant Pharmaceutical pre-clinical safety 0€ - 10,000€ Avacta Life Sciences Safety of pharmaceutical impurities 0€ - 10,000€ Japan Tobacco Pharmaceutical pre-clinical safety 0€ - 10,000€ MedPass International REACH registration 0€ - 10,000€ Clients for current financial year
Clients list
Name lemonex inc Destiny Pharma palladio biosciences inc Summit Pharmaceuticals Abliva AB Medherant ultragenyx pharmaceutical inc galapagos pharma denali therapeutics inc NXTLEVVEL Biochem BV noema pharma ag Leveret GmbH Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None.
Other activities
None declared
Meetings
Meetings
None declared